English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Apr 16, 2026
Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’
Patient Daily
| Apr 10, 2026
Heartland Institute's Milloy on vaccine liability: 'Simply ending immunity on vaccines will only make things worse'
Patient Daily
| Apr 10, 2026
Cornell Health Policy Center survey: 78% of experts say weakening vaccine liability protections would curb innovation
Patient Daily
| Apr 9, 2026
Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
Patient Daily
| Apr 8, 2026
Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
A. D. Brady
| Mar 30, 2026
Consumer Choice Advocate: RFK Jr. helped ‘dubious claims gain credibility in courtrooms’
Patient Daily
| Mar 30, 2026
Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
Patient Daily
| Mar 30, 2026
Biotechnology Innovation Organization survey finds strong voter support for PBM reforms
Trending
+
Pharmaceuticals
Patient Daily
| May 26, 2026
ASCO 2026 to spotlight Revolution Medicines and bispecific antibody advances
+
Regulatory
Patient Daily
| May 26, 2026
Senate candidate Dr. El-Sayed on PBMs: ‘They just extract profit from patients’
+
Regulatory
A. J. Alarcon
| May 26, 2026
Ellen Lubensky discusses mental health reform and informed consent on Health Policy Podcast
+
Regulatory
Patient Daily
| May 25, 2026
National Alliance of Healthcare Purchaser Coalitions chief of staff on 340B: ‘340B needs a big dose of transparency’
« First
«
1
2
3
»
Last »